• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海绵吡喃的合成研究。(+)-海绵他汀2的全合成。

Spongipyran Synthetic Studies. Total Synthesis of (+)-Spongistatin 2.

作者信息

Smith Amos B, Lin Qiyan, Doughty Victoria A, Zhuang Linghang, McBriar Mark D, Kerns Jeffrey K, Boldi Armen M, Murase Noriaki, Moser William H, Brook Christopher S, Bennett Clay S, Nakayama Kiyoshi, Sobukawa Masao, Lee Trout Robert E

机构信息

Department of Chemistry, Monell Chemical Senses Center and Laboratory for Research on the Structure of Matter, University of Pennsylvania, Philadelphia, PA, 19104.

出版信息

Tetrahedron. 2009 Aug 15;65(33):6470-6488. doi: 10.1016/j.tet.2009.04.001.

DOI:10.1016/j.tet.2009.04.001
PMID:20161196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2712115/
Abstract

Evolution of a convergent synthetic strategy to access (+)-spongistatin 2 (2), a potent cytotoxic marine macrolide, is described. Highlights of the synthesis include: development of a multicomponent dithiane-mediated linchpin union tactic, devised and implemented specifically for construction of the spongistatin AB and CD spiro ring systems; application of a Ca(II) ion controlled acid promoted equilibration to set the thermodynamically less stable axial-equitorial stereogenicity in the CD spiroketal; use of sulfone addition/Julia methylenation sequences to unite the AB and CD fragments and introduce the C(44)-C(51) side chain; and fragment union and final elaboration to (+)-spongistatin 2 (2) exploiting Wittig olefination to unite the advanced ABCD and EF fragments, followed by regioselective Yamaguchi macrolactonization and global deprotection. Correction of the CD spiro ring stereogenicity was subsequently achieved via acid equilibration in the presence of Ca(II) ion to furnish (+)-spongistatin 2 (2). The synthesis proceeded with a longest linear sequence of 41 steps.

摘要

本文描述了一种用于合成强效细胞毒性海洋大环内酯类化合物(+)-海绵他汀2(2)的收敛性合成策略的演变。该合成的亮点包括:开发了一种多组分二硫烷介导的关键连接策略,该策略是专门为构建海绵他汀AB和CD螺环系统而设计和实施的;应用Ca(II)离子控制的酸促进平衡来设置CD螺环酮中热力学上较不稳定的轴向-赤道立体化学;使用砜加成/朱莉娅亚甲基化序列来连接AB和CD片段并引入C(44)-C(51)侧链;以及利用维蒂希烯烃化反应将高级ABCD和EF片段连接起来,随后进行区域选择性山口大环内酯化和全局脱保护,从而将片段连接并最终合成(+)-海绵他汀2(2)。随后通过在Ca(II)离子存在下进行酸平衡来校正CD螺环的立体化学,以得到(+)-海绵他汀2(2)。该合成以最长41步的线性序列进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/444660e47a3e/nihms112913f48.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/67bd79f8a7ed/nihms112913f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/93ec11f0cd15/nihms112913f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/19aa1e8b09f9/nihms112913f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e18accc32320/nihms112913f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/55768cd8c53e/nihms112913f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/122ec60438f9/nihms112913f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2905dca78eca/nihms112913f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f0ae9bd2eab3/nihms112913f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f4e8938649c3/nihms112913f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e3bff0c06ff6/nihms112913f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/d135c22df195/nihms112913f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/8c97fde620ab/nihms112913f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/32ecf71df4cd/nihms112913f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/8e63f5c5a3bb/nihms112913f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/1af411ad5582/nihms112913f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/0aae4f76bc90/nihms112913f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/7a43a027bffd/nihms112913f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9a76bd195bd5/nihms112913f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b4d7c08a19d7/nihms112913f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9e29fa143107/nihms112913f20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/5a41a760cdc8/nihms112913f21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b1e49f510b58/nihms112913f22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/3f946b00da31/nihms112913f23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/735e929dcb75/nihms112913f24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/48a42a4ccef9/nihms112913f25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/af49b1fc1fb1/nihms112913f26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/502a71cca32b/nihms112913f27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9a6c9078b94f/nihms112913f28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/d33b4e2aca4c/nihms112913f29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/53e5633c8b1e/nihms112913f30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2448bd1cc853/nihms112913f31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/75b27f0c4070/nihms112913f32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/368177f35af1/nihms112913f33.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e54f055f8b78/nihms112913f34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/6dced8a93b0f/nihms112913f35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2b7d14340003/nihms112913f36.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/fe7cee7782c1/nihms112913f37.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/a3e4b47f7c32/nihms112913f38.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/3bd074008776/nihms112913f39.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/15e019e28429/nihms112913f40.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e43388ad75ec/nihms112913f41.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/87c1c013148f/nihms112913f42.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/ceaabbd8d099/nihms112913f43.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f327750271e6/nihms112913f44.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2d729e86607f/nihms112913f45.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/412afd608d11/nihms112913f46.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b5046c26f8c5/nihms112913f47.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/444660e47a3e/nihms112913f48.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/67bd79f8a7ed/nihms112913f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/93ec11f0cd15/nihms112913f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/19aa1e8b09f9/nihms112913f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e18accc32320/nihms112913f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/55768cd8c53e/nihms112913f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/122ec60438f9/nihms112913f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2905dca78eca/nihms112913f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f0ae9bd2eab3/nihms112913f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f4e8938649c3/nihms112913f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e3bff0c06ff6/nihms112913f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/d135c22df195/nihms112913f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/8c97fde620ab/nihms112913f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/32ecf71df4cd/nihms112913f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/8e63f5c5a3bb/nihms112913f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/1af411ad5582/nihms112913f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/0aae4f76bc90/nihms112913f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/7a43a027bffd/nihms112913f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9a76bd195bd5/nihms112913f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b4d7c08a19d7/nihms112913f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9e29fa143107/nihms112913f20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/5a41a760cdc8/nihms112913f21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b1e49f510b58/nihms112913f22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/3f946b00da31/nihms112913f23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/735e929dcb75/nihms112913f24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/48a42a4ccef9/nihms112913f25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/af49b1fc1fb1/nihms112913f26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/502a71cca32b/nihms112913f27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/9a6c9078b94f/nihms112913f28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/d33b4e2aca4c/nihms112913f29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/53e5633c8b1e/nihms112913f30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2448bd1cc853/nihms112913f31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/75b27f0c4070/nihms112913f32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/368177f35af1/nihms112913f33.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e54f055f8b78/nihms112913f34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/6dced8a93b0f/nihms112913f35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2b7d14340003/nihms112913f36.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/fe7cee7782c1/nihms112913f37.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/a3e4b47f7c32/nihms112913f38.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/3bd074008776/nihms112913f39.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/15e019e28429/nihms112913f40.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/e43388ad75ec/nihms112913f41.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/87c1c013148f/nihms112913f42.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/ceaabbd8d099/nihms112913f43.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/f327750271e6/nihms112913f44.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/2d729e86607f/nihms112913f45.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/412afd608d11/nihms112913f46.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/b5046c26f8c5/nihms112913f47.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8fc/2712115/444660e47a3e/nihms112913f48.jpg

相似文献

1
Spongipyran Synthetic Studies. Total Synthesis of (+)-Spongistatin 2.海绵吡喃的合成研究。(+)-海绵他汀2的全合成。
Tetrahedron. 2009 Aug 15;65(33):6470-6488. doi: 10.1016/j.tet.2009.04.001.
2
Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1.海绵吡喃的合成研究。(+)-海绵他汀1的可扩展全合成的演变
Tetrahedron. 2009 Sep 15;65(33):6489-6509. doi: 10.1016/j.tet.2009.04.003.
3
Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration.
Org Lett. 2003 Mar 6;5(5):761-4. doi: 10.1021/ol034037a.
4
Gram-scale synthesis of (+)-spongistatin 1: development of an improved, scalable synthesis of the F-ring subunit, fragment union, and final elaboration.克级规模合成(+)-海绵他汀1:F环亚基改良可扩展合成方法的开发、片段连接及最终修饰。
Org Lett. 2008 Oct 2;10(19):4359-62. doi: 10.1021/ol801792k. Epub 2008 Aug 28.
5
Spongistatin synthetic studies. evolution of a scalable synthesis for the EF fragment of (+)-Spongistatin 1 exploiting a Petasis-Ferrier union/rearrangement tactic.海绵他汀的合成研究。利用Petasis-Ferrier偶联/重排策略开发(+)-海绵他汀1的EF片段的可扩展合成方法的进展。
Org Lett. 2004 Sep 30;6(20):3637-40. doi: 10.1021/ol048418f.
6
Asymmetric total synthesis of spongistatins 1 and 2.海绵他汀1和2的不对称全合成。
J Am Chem Soc. 2002 May 22;124(20):5661-3. doi: 10.1021/ja0262683.
7
Spongistatin synthetic studies. An efficient, second-generation construction of an advanced ABCD intermediate.
Org Lett. 2002 Mar 7;4(5):783-6. doi: 10.1021/ol017273z.
8
Synthesis of the C1-C28 Portion of Spongistatin 1 (Altohyrtin A).海绵他汀1(高海葵毒素A)C1 - C28部分的合成
J Org Chem. 1999 Oct 29;64(22):8267-8274. doi: 10.1021/jo9910987.
9
Synthesis of the C-1-C-28 ABCD unit of spongistatin 1.海绵他汀1中C-1 - C-28 ABCD单元的合成。
Org Lett. 2003 Dec 11;5(25):4819-22. doi: 10.1021/ol035849+.
10
Multigram synthesis of the C29-C51 subunit and completion of the total synthesis of altohyrtin C (spongistatin 2).C29 - C51亚基的多克级合成以及altohyrtin C(海绵抑素2)全合成的完成。
J Am Chem Soc. 2003 Oct 22;125(42):12844-9. doi: 10.1021/ja030317+.

引用本文的文献

1
Total Synthesis of (-)-Bastimolide A: A Showcase for Type I Anion Relay Chemistry.(-)-Bastimolide A 的全合成:I 型阴离子接力化学的典范。
Angew Chem Int Ed Engl. 2022 Jul 11;61(28):e202204884. doi: 10.1002/anie.202204884. Epub 2022 May 24.
2
Iodine/water-mediated deprotective oxidation of allylic ethers to access α,β-unsaturated ketones and aldehydes.碘/水介导的烯丙基醚脱保护氧化反应以制备α,β-不饱和酮和醛。
RSC Adv. 2020 Apr 14;10(25):14720-14724. doi: 10.1039/d0ra02625e. eCollection 2020 Apr 8.
3
Concise Large-Scale Synthesis of Tomatidine, A Potent Antibiotic Natural Product.

本文引用的文献

1
Chiral synthesis via organoboranes. 7. Diastereoselective and enantioselective synthesis of erythro- and threo-.beta.-methylhomoallyl alcohols via enantiomeric (Z)- and (E)-crotylboranes.通过有机硼烷进行手性合成。7. 通过对映体(Z)-和(E)-巴豆基硼烷非对映选择性和对映选择性合成赤式和苏式β-甲基高烯丙醇。
J Am Chem Soc. 1986 Sep 1;108(19):5919-23. doi: 10.1021/ja00279a042.
2
Ortho-TMS benzaldehyde: an effective linchpin for type II anion relay chemistry (ARC).邻位三甲基硅基苯甲醛:II型阴离子接力化学(ARC)的有效关键物质。
Angew Chem Int Ed Engl. 2008;47(37):7082-6. doi: 10.1002/anie.200802301.
3
The [1,5]-Brook rearrangement: an initial application in anion relay chemistry.
简明大规模合成番茄次碱,一种强效抗生素天然产物。
Molecules. 2021 Oct 3;26(19):6008. doi: 10.3390/molecules26196008.
4
Design and 22-step synthesis of highly potent D-ring modified and linker-equipped analogs of spongistatin 1.高度有效的海绵抑素 1 的 D 环修饰和连接子装备的类似物的设计和 22 步合成。
Nat Commun. 2018 Nov 9;9(1):4710. doi: 10.1038/s41467-018-07259-x.
5
Conformation-activity relationships of polyketide natural products.聚酮类天然产物的构象-活性关系
Nat Prod Rep. 2015 Aug;32(8):1183-206. doi: 10.1039/c5np00014a.
6
Toward a more step-economical and scalable synthesis of spongistatin 1 to facilitate cancer drug development efforts.朝着更具步骤经济性和可扩展性的海绵他汀1合成方向发展,以促进癌症药物开发工作。
Chem Sci. 2013 Apr 1;4(4):1497-1501. doi: 10.1039/C3SC22186E.
7
Complex fragment coupling by crotylation: A powerful tool for polyketide natural product synthesis.通过巴豆酰化进行复杂片段偶联:聚酮天然产物合成的有力工具。
Chem Sci. 2012 Nov 1;3(11):3326-3330. doi: 10.1039/C2SC21325G.
8
Exploiting pseudo C2-symmetry for an efficient synthesis of the F-ring of the spongistatins.利用伪 C2 对称性高效合成海绵抑素的 F 环。
Org Lett. 2013 Nov 1;15(21):5464-7. doi: 10.1021/ol402604s. Epub 2013 Oct 10.
9
Toward an enantioselective synthesis of (-)-zampanolide: preparation of the C9-C20 region.在手性全合成(-)-扎潘诺内酯的研究中:C9-C20 区域的构建。
Org Lett. 2012 Jul 6;14(13):3408-11. doi: 10.1021/ol301383a. Epub 2012 Jun 21.
10
Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned.微小 (+)-海绵抑素 1 类似物的设计、合成与生物评价:经验总结。
J Am Chem Soc. 2011 Sep 7;133(35):14042-53. doi: 10.1021/ja2046167. Epub 2011 Aug 12.
[1,5]-布鲁克重排反应:阴离子接力化学中的首次应用
J Am Chem Soc. 2006 Sep 27;128(38):12368-9. doi: 10.1021/ja065033e.
4
Anion relay chemistry: an effective tactic for diversity oriented synthesis.阴离子接力化学:一种用于多样性导向合成的有效策略。
J Am Chem Soc. 2006 Jan 11;128(1):66-7. doi: 10.1021/ja057059w.
5
Total synthesis of spongistatin 1: a synthetic strategy exploiting its latent pseudo-symmetry.海绵他汀1的全合成:一种利用其潜在拟对称性的合成策略。
Angew Chem Int Ed Engl. 2005 Aug 26;44(34):5433-8. doi: 10.1002/anie.200502008.
6
Synthesis of the C-1-C-28 ABCD unit of spongistatin 1.海绵他汀1中C-1 - C-28 ABCD单元的合成。
Org Lett. 2003 Dec 11;5(25):4819-22. doi: 10.1021/ol035849+.
7
Multicomponent linchpin couplings. Reaction of dithiane anions with terminal epoxides, epichlorohydrin, and vinyl epoxides: efficient, rapid, and stereocontrolled assembly of advanced fragments for complex molecule synthesis.多组分关键偶联反应。二硫烷阴离子与末端环氧化物、环氧氯丙烷和乙烯基环氧化物的反应:用于复杂分子合成的高级片段的高效、快速且立体控制的组装。
J Am Chem Soc. 2003 Nov 26;125(47):14435-45. doi: 10.1021/ja0376238.
8
Multigram synthesis of the C29-C51 subunit and completion of the total synthesis of altohyrtin C (spongistatin 2).C29 - C51亚基的多克级合成以及altohyrtin C(海绵抑素2)全合成的完成。
J Am Chem Soc. 2003 Oct 22;125(42):12844-9. doi: 10.1021/ja030317+.
9
A second-generation synthesis of the C1-C28 portion of the altohyrtins (spongistatins).海绵抑素(altohyrtins)C1 - C28部分的第二代合成。
J Am Chem Soc. 2003 Oct 22;125(42):12836-43. doi: 10.1021/ja030316h.
10
Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration.
Org Lett. 2003 Mar 6;5(5):761-4. doi: 10.1021/ol034037a.